Atezolizumab
RG1123580
Phase 2 mab terminated
Quick answer
Atezolizumab for Metastatic Lung Non-Small Cell Carcinoma is a Phase 2 program (mab) at Oncotelic Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Oncotelic Therapeutics
- Indication
- Metastatic Lung Non-Small Cell Carcinoma
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated